Multiple Sclerosis Therapeutics Market

Multiple Sclerosis Therapeutics Market
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Multiple Sclerosis Therapeutics Market – Overview
Multiple Sclerosis Therapeutics Market – Offering Long-term Disease Management
Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain
and spinal cord are damaged. The disease leads in malfunction of the nervous system to communicate,
which in turn causes several signs and symptoms, including physical, mental, and psychiatric problems.
Double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination
are some of the other symptoms.
The types of MS include relapsing-remitting MS (RRMS), primary progressive MS (PPMS), and secondary
progressive MS (SPMS). RPMS is the most common type characterized by defined attacks with increasing
neurological symptoms, PPMS is the rare form characterized by gradual progression of disease, whereas
SPMS is commonly identified in people living with relapsed-remitting MS. The most common symptoms
of the disease include partial or complete vision loss, prolonged vision loss, lack of coordination, and
slurred speech.
REPORT DESCRIPTION
Multiple Sclerosis Therapeutics Market – Taxonomy
Global Multiple Sclerosis Therapeutics Market, By Drug Class:
Beta Interferon
Corticosteroids
Monoclonal Antibodies
Antineoplastic Agents
Others
Download PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/1310
REPORT DESCRIPTION
Multiple Sclerosis Therapeutics Market – Key Players
• Novartis AG, Teva Pharmaceutical Industries Ltd.,
• Sanofi S.A., Bayer AG, Pfizer, Inc.,
• Biogen Idec,
• Merck & Co., Inc., and AbbVie, Inc.
Read More @
https://www.coherentmarketinsights.com/market-insight/multiple-sclerosis-therapeutics-market-1310
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
MEDICAL DEVICES




CLINICAL
DIAGNOSTIC
MEDICAL IMAGING
Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
 Private and Government organization
 Outsourcing Companies
 Universities and Business Schools.
HEALTHCARE IT
PHARMACEUTICAL
ABOUT US
KEY STATS
100
+
150+
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
Insights Published Per Year
Consulting Projects Till
Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract
Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702

The multiple sclerosis therapeutic agents are intended to promote neurorepair and neuroprotection to prevent disease progression. The disease modifying therapeutics are currently under clinical development to specifically target the disease while avoiding frequent therapeutic administrations. A variety of corticosteroids, immunosuppressants and monoclonal antibodies are approved and recommended to reduce inflammation in multiple sclerosis.

Download Report